Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Immuron

IMRN

IMRN Immuron NASDAQ
Add to watchlist
241.40
-1.72 (-0.71 %)
At close : Jan 03, 16:00 ET
--
  • Post market
  • 20:00 ET
    Summary
    Options
    Financials
    News
    Filings
    Profile
    IMRN Chart
    See on advanced chart >
    • Volume --
    • Turnover --
    • P/E(TTM) --
    • Turnover % --
    • P/E(Static) --
    • Market Cap --
    • P/B --
    • Shares --
    • 52 Week Range
    • Day Range

    About

    Immuron Limited was incorporated under the laws of Australia in 1994. The company is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on the development and commercialization of a novel class of...
    • Highlight
      An Australian developer of immunomodulator polyclonal antibodies that treats liver disease and infectious diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/09/2017
    • Established Date
      Invalid Date
    • Full-time Employees
      7
    • Address
      Level 3 62 Lygon Street Carlton South Victoria 3053 Australia
    • Tel
      61-3-98245254
    • Website
    • Fiscal Year End Date
      06/30
    • Security Type
      American Depositary Receipt (Common Stock)

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App